Treating bleeding and bleeding disorders via high intensity focused ultrasound stimulation of the spleen
AssigneeThe Feinstein Institutes for Medical Research
InventorsJared M. Huston, Jason R. Fritz, Catherine W. Imossi, Kevin J. Tracey
Life of this patent
Estimating the term…
Abstract
Apparatuses and methods for reducing or limiting bleeding in an animal by focused ultrasound (FUS) stimulation of the spleen. The apparatuses and methods may be used treat blood disorders such as hemophilia, or to reduce hemorrhage in surgery or due to traumatic injury. The methods may be non-invasively administered to the patient by transcutaneous application of ultrasound energy.
Claims18
A system for reducing blood loss in a subject, the system comprising:
- an ultrasound applicator comprising one or more ultrasound transmitters and a housing configured to apply ultrasound stimulation to the subject's spleen, wherein the housing is configured to be secured to the subject's abdomen over the subject's spleen;
- and
- a controller coupled to the ultrasound applicator, the controller configured to deliver ultrasound stimulation from the one or more ultrasound transmitters at a frequency of between 0.25 to 5.0 MHz by applying an input voltage amplitude ranging from 50 to 350 mVpp to drive application of ultrasound from the ultrasound applicator for a duration ranging from 30 seconds to 5 minutes to the subject's spleen to target activation of the blood coagulation pathway and reduce bleed time in the subject by at least 20%.
A method of reducing blood loss in a subject, the method comprising:
- applying ultrasound stimulation non-invasively to the subject's spleen from one or more ultrasound transmitters at a frequency of between 0.25 to 5.0 MHz by applying an input voltage amplitude ranging from 50 to 350 mVpp to drive application of ultrasound from an ultrasound applicator for a duration ranging from 30 seconds to 5 minutes;
- and
- reducing bleed time by at least 20%, wherein applying the ultrasound stimulation includes applying the ultrasound stimulation to the subject's spleen to target activation of the blood coagulation pathway without directly stimulating trigeminal nerve.
A system for reducing blood loss in a subject, the system comprising:
- an ultrasound applicator comprising one or more ultrasound transmitters and a housing configured to apply ultrasound stimulation to the subject's spleen, wherein the ultrasound applicator comprises one or more sensors, further wherein the controller is configured to detect an intercostal space and to select one or more of the ultrasound transmitters of the ultrasound applicator overlaying the intercostal space;
- and
- a controller coupled to the ultrasound applicator, the controller configured to deliver ultrasound stimulation from the one or more ultrasound transmitters at a frequency of between 0.25 to 5.0 MHz by applying an input voltage amplitude ranging from 50 to 350 mVpp to drive application of ultrasound from the ultrasound applicator for a duration ranging from 30 seconds to 5 minutes to the subject's spleen to target activation of the blood coagulation pathway and reduce bleed time in the subject by at least 20%.
Dependencies are inferred from the claim text.